Trish Hepburn

753 total citations
24 papers, 307 citations indexed

About

Trish Hepburn is a scholar working on Microbiology, Epidemiology and Physiology. According to data from OpenAlex, Trish Hepburn has authored 24 papers receiving a total of 307 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Microbiology, 7 papers in Epidemiology and 6 papers in Physiology. Recurrent topics in Trish Hepburn's work include Reproductive tract infections research (8 papers), Syphilis Diagnosis and Treatment (5 papers) and Adolescent Sexual and Reproductive Health (4 papers). Trish Hepburn is often cited by papers focused on Reproductive tract infections research (8 papers), Syphilis Diagnosis and Treatment (5 papers) and Adolescent Sexual and Reproductive Health (4 papers). Trish Hepburn collaborates with scholars based in United Kingdom, South Africa and Denmark. Trish Hepburn's co-authors include Alan Montgomery, Wei Tan, Jonathan Ross, Lelia Duley, Clare Brittain, Richard Eastgate, Sue Cobb, Tracy Roberts, A. Foss and Kirsty Sprange and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Trish Hepburn

23 papers receiving 300 citations

Peers

Countries citing papers authored by Trish Hepburn

Since Specialization

Citations

This map shows the geographic impact of Trish Hepburn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Trish Hepburn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Trish Hepburn more than expected).

Fields of papers citing papers by Trish Hepburn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Trish Hepburn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Trish Hepburn. The network helps show where Trish Hepburn may publish in the future.

Co-authorship network of co-authors of Trish Hepburn

This figure shows the co-authorship network connecting the top 25 collaborators of Trish Hepburn. A scholar is included among the top collaborators of Trish Hepburn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Trish Hepburn. Trish Hepburn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Developing an adaptive platform trial for evaluation of medical treatments for Crohn’s disease 2025 ·Nature Reviews Gastroenterology & Hepatology ·Nurulamin M Noor, Shellie Radford, Babak Choodari‐Oskooei, Morris Gordon, Ailsa Hart, Trish Hepburn, Edmund Juszczak, James O. Lindsay, Nicholas A. Kennedy, Mahesh Parmar, (unknown), Gordon W. Moran	1
2	Intravaginal lactic acid gel versus oral metronidazole for treating women with recurrent bacterial vaginosis: the VITA randomised controlled trial 2023 ·BMC Women s Health ·Jonathan Ross, Clare Brittain, Jocelyn Anstey Watkins, Joe Kai, Miruna David, Mara Ozolins, Louise Jackson, (unknown), Trish Hepburn, Frances Griffiths, Alan Montgomery, Jane Daniels, (unknown), Gillian Dean, (unknown)	6
3	Effectiveness and cost effectiveness of digital hearing aids in patients with tinnitus and hearing loss: a randomised feasibility trial (THE HUSH Trial) 2022 ·Pilot and Feasibility Studies ·Rachel Haines, Trish Hepburn, Wei Tan, Clare Jackson, (unknown), (unknown), (unknown), Richard Nicholson, David Stockdale, Paul Leighton, Marilyn James, Magdalena Sereda	3
4	How is oral isotretinoin prescribed for the treatment of acne vulgaris? Results from a UK Dermatology Clinical Trials Network (UKDCTN) and British Dermatological Nursing Group (BDNG) survey of health professionals 2022 ·Clinical and Experimental Dermatology ·(unknown), (unknown), Jane Ravenscroft, Eugene Healy, (unknown), Kim S Thomas, Esther Burden‐Teh, (unknown), Trish Hepburn, (unknown), Alison Layton, Paul Leighton, (unknown), (unknown), (unknown), (unknown), (unknown), Tracey Sach, (unknown), Andrew R. Thompson, (unknown), Hywel C Williams	0
5	Factors associated with time to presentation for individuals with symptomatic uncomplicated genital gonorrhoea: a cross sectional cohort study of GToG trial participants 2020 ·Sexually Transmitted Infections ·Oluseyi Ayinde, Wei Tan, Trish Hepburn, Jonathan Ross	3
6	Desmopressin for reversal of Antiplatelet drugs in Stroke due to Haemorrhage (DASH): protocol for a phase II double-blind randomised controlled feasibility trial 2020 ·BMJ Open ·Michael Desborough, Rustam Al‐Shahi Salman, Simon Stanworth, Diane Havard, Paul M. Brennan, Robert A. Dineen, Tim Coats, Trish Hepburn, Philip M. Bath, Nikola Sprigg	5
7	A randomised feasibility trial comparing needle fasciotomy with limited fasciectomy treatment for Dupuytren’s contractures 2020 ·Pilot and Feasibility Studies ·(unknown), Tim Davis, Wei Tan, Eleanor Harrison, William Hollingworth, Alexia Karantana, Nicola Mills, Trish Hepburn, Kirsty Sprange, Lelia Duley, Jane Blazeby, L.C. Bainbridge, S. R. Murali, Alan Montgomery	6
8	Protocol for a multi-centre randomised controlled stand-alone feasibility trial to assess potential effectiveness and cost-effectiveness of digital hearing aids in patients with tinnitus and hearing loss (the HUSH trial) 2020 ·Pilot and Feasibility Studies ·Rachel Haines, (unknown), Garry Meakin, Wei Tan, Trish Hepburn, Paul Leighton, (unknown), David Stockdale, (unknown), Richard Nicholson, Deborah A. Hall, Magdalena Sereda	4
9	Eicosapentaenoic acid and/or aspirin for preventing colorectal adenomas during colonoscopic surveillance in the NHS Bowel Cancer Screening Programme: the seAFOod RCT 2019 ·SHILAP Revista de lepidopterología ·Mark A. Hull, Kirsty Sprange, Trish Hepburn, Wei Tan, Aisha Shafayat, Colin Rees, Gayle Clifford, Richard F. Logan, Paul M. Loadman, Elizabeth A. Williams, Diane Whitham, Alan Montgomery	13
10	Gentamicin as an alternative to ceftriaxone in the treatment of gonorrhoea: the G-TOG non-inferiority RCT 2019 ·Health Technology Assessment ·Jonathan Ross, J. W. Harding, Lelia Duley, Alan Montgomery, Trish Hepburn, Wei Tan, Clare Brittain, Garry Meakin, Kirsty Sprange, (unknown), Louise Jackson, Tracy Roberts, Janet Wilson, John Albert White, Claire Dewsnap, Michelle Cole, (unknown)	2
11	Gentamicin compared with ceftriaxone for the treatment of gonorrhoea (G-ToG): a randomised non-inferiority trial 2019 ·The Lancet ·Jonathan Ross, Clare Brittain, Michelle Cole, Claire Dewsnap, J. W. Harding, Trish Hepburn, Louise Jackson, (unknown), (unknown), Alan Montgomery, Tracy Roberts, Kirsty Sprange, Wei Tan, (unknown), (unknown), Janet Wilson, Lelia Duley	76
12	Home interventions and light therapy for the treatment of vitiligo (HI-Light Vitiligo Trial): study protocol for a randomised controlled trial 2018 ·BMJ Open ·Rachel Haines, Kim S Thomas, Alan Montgomery, Jane Ravenscroft, (unknown), Joanne R Chalmers, Diane Whitham, Lelia Duley, Viktoria Eleftheriadou, Garry Meakin, Eleanor Mitchell, (unknown), Andy Rogers, Tracey Sach, Miriam Santer, Wei Tan, Trish Hepburn, Hywel C Williams, Jonathan Batchelor	5
13	Reduced fetal movement intervention Trial-2 (ReMIT-2): protocol for a pilot randomised controlled trial of standard care informed by the result of a placental growth factor (PlGF) blood test versus standard care alone in women presenting with reduced fetal movement at or after 36+ 0 weeks gestation 2018 ·Trials ·(unknown), Eleanor Mitchell, Trish Hepburn, Lelia Duley, Jim Thornton, Tracy Roberts, Claire Storey, Rebecca MD Smyth, Alexander Heazell	8
14	Central masked adjudication of stroke diagnosis at trial entry offered no advantage over diagnosis by local clinicians: Secondary analysis and simulation 2018 ·Contemporary Clinical Trials Communications ·Peter J. Godolphin, Trish Hepburn, Nikola Sprigg, (unknown), Eivind Berge, Rónán Collins, John Gommans, George Ntaios, Stuart Pocock, Kameshwar Prasad, Joanna M. Wardlaw, Philip M. Bath, Alan Montgomery	3
15	Ambulance-delivered transdermal glyceryl trinitrate versus sham for ultra-acute stroke: Rationale, design and protocol for the Rapid Intervention with Glyceryl trinitrate in Hypertensive stroke Trial-2 (RIGHT-2) trial (ISRCTN26986053) 2017 ·International Journal of Stroke ·Jason P. Appleton, Polly Scutt, Mark Dixon, (unknown), (unknown), Diane Havard, Trish Hepburn, Timothy J. England, Nikola Sprigg, Lisa J Woodhouse, Joanna M. Wardlaw, Alan Montgomery, Stuart Pocock, Philip M. Bath, (unknown)	12
16	Investigating the effect of independent, blinded digital image assessment on the STOP GAP trial 2017 ·Trials ·(unknown), Peter J. Godolphin, Kim S Thomas, Trish Hepburn, Eleanor Mitchell, Fiona E. Craig, Philip M. Bath, Alan Montgomery	5
17	Gentamicin versus ceftriaxone for the treatment of gonorrhoea (G-TOG trial): study protocol for a randomised trial 2016 ·Trials ·Clare Brittain, Margaret Childs, Lelia Duley, J. W. Harding, Trish Hepburn, Garry Meakin, Alan Montgomery, Wei Tan, Jonathan Ross	9
18	Evaluation and development of a novel binocular treatment (I-BiT™) system using video clips and interactive games to improve vision in children with amblyopia (‘lazy eye’): study protocol for a randomised controlled trial 2013 ·Trials ·A. Foss, Richard Gregson, (unknown), (unknown), Isabel M Ash, Sue Cobb, Richard Eastgate, Trish Hepburn, Anthony J. Vivian, (unknown), S M Haworth, (unknown)	24
19	Interactive binocular treatment (I-BiT) for amblyopia: results of a pilot study of 3D shutter glasses system 2013 ·Eye ·(unknown), (unknown), Sue Cobb, R Gregson, Isabel M Ash, Richard Eastgate, (unknown), Trish Hepburn, (unknown), A. Foss	50
20	The role of the novel D2/beta2-agonist, Viozan (sibenadet HCl), in the treatment of symptoms of chronic obstructive pulmonary disease: results of a large-scale clinical investigation. 2003 ·PubMed ·L. C. Laursen, Ari Lindqvist, Trish Hepburn, (unknown), John Perrett, (unknown), (unknown)	20

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact